A retrospective multicenter study assessing the efficacy and safety of neoadjuvant pertuzumab, trastuzumab and chemotherapy in non-metastatic HER2-positive breast cancer in the Asian population
Latest Information Update: 09 Nov 2020
At a glance
- Drugs Pertuzumab (Primary) ; Trastuzumab (Primary) ; Carboplatin; Cyclophosphamide; Doxorubicin; Doxycycline; Paclitaxel
- Indications Breast cancer; HER2 positive breast cancer
- Focus Therapeutic Use
- 09 Nov 2020 New trial record
- 03 Oct 2020 Results presented at the Official 12th European Breast Cancer Conference